IUHSA
MYGN icon

Itau Unibanco Holding S.A.’s Myriad Genetics MYGN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-203
Closed -$4.96K – 396
2024
Q2 		$4.96K Buy
+203
New +$4.45K ﹤0.01% 320
2022
Q4 		– Sell
-2,405
Closed -$46K – 599
2022
Q3 		$46K Sell
2,405
-973
-29% -$22.3K ﹤0.01% 397
2022
Q2 		$61K Buy
3,378
+451
+15% +$9.37K ﹤0.01% 322
2022
Q1 		$74K Hold
2,927
– – ﹤0.01% 283
2021
Q4 		$81K Buy
+2,927
New +$84.8K ﹤0.01% 240

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Itau Unibanco Holding S.A.'s MYGN Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Myriad Genetics (MYGN) in Q3 2024, closing a stake of 203 shares — an estimated $4.96K sold.

Itau Unibanco Holding S.A. first reported a position in MYGN in Q4 2021 and held it in 5 quarters. The position peaked at $81K in Q4 2021. 246 funds tracked by Wall St. Rank hold MYGN as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Myriad Genetics position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 203 Myriad Genetics shares in Q3 2024, an estimated $4.96K.
  • Itau Unibanco Holding S.A. first reported a position in Myriad Genetics in Q4 2021 and held it in 5 quarters.
  • Itau Unibanco Holding S.A.'s Myriad Genetics position peaked at $81K in Q4 2021.
  • 246 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.